NCT06953661 Ultrasound Guided Stellate Ganglion Block in Postural Tachycardia Syndrome
| NCT ID | NCT06953661 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Postural Tachycardia Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-10-16 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-10-16 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This single-center study aims to evaluate both immediate and long-term outcomes of stellate ganglion block (SGB) in a cohort of rigorously phenotyped patients with Postural Tachycardia Syndrome (POTS). By assessing the effects of SGB, this study seeks to determine its viability as an intervention for symptom control in POTS.
Eligibility Criteria
Inclusion Criteria: * Adult patients (\>18 years of age) diagnosed with POTS * Ability to provide informed consent * Ability to comply with 3 follow up visits * English speaking and capable of signing informed consent and complying with protocol requirements Exclusion Criteria: * Allergy to local anesthetics * Severe coagulopathy * History of or currently being treated for clinically significant ongoing cardiac arrhythmia, heart failure, myocarditis, pulmonary embolism requiring anticoagulation, pulmonary fibrosis or other pulmonary diagnosis that in the investigator's opinion may contribute to symptoms of POTS * Inability to maintain a stable medication regiment for the duration of the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06953661 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Postural Tachycardia Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06953661 currently recruiting?
Yes, NCT06953661 is actively recruiting participants. Contact the research team at abomba@stanford.edu for enrollment information.
Where is the NCT06953661 trial being conducted?
This trial is being conducted at Stanford, United States, Stanford, United States.
Who is sponsoring the NCT06953661 clinical trial?
NCT06953661 is sponsored by Stanford University. The trial plans to enroll 20 participants.